SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-104263
Filing Date
2022-04-13
Accepted
2022-04-13 16:05:53
Documents
3
Period of Report
2022-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d276905ddef14a.htm DEF 14A 304083
2 GRAPHIC g276905g22s22.jpg GRAPHIC 148189
3 GRAPHIC g276905g23s23.jpg GRAPHIC 144380
  Complete submission text file 0001193125-22-104263.txt   708458
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Filer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39782 | Film No.: 22824765
SIC: 2836 Biological Products, (No Diagnostic Substances)